Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma

Ai Di Gu; Hao Yuan Mo; Jin Xin Bei; Yan Bo Xie; Li Zhen Chen; Qi Sheng Feng; Tiebang Kang; Yi Xin Zeng

doi:10.1128/CVI.00207-08

Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma

Ai Di Gu
, Hao Yuan Mo
, Jin Xin Bei
, Yan Bo Xie
, Li Zhen Chen
, Qi Sheng Feng
, Tiebang Kang
, Yi Xin Zeng

科研成果: 期刊稿件 › 文章 › 同行评审

3 引用（Scopus）

摘要

Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.

源语言	英语
页（从-至）	592-593
页数	2
期刊	Clinical and Vaccine Immunology
卷	16
期	4
DOI	https://doi.org/10.1128/CVI.00207-08
出版状态	已出版 - 4月 2009
已对外发布	是

访问文件

10.1128/CVI.00207-08

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{2ac2d66603604ba8a2ff0ff35a11f8de,

title = "Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma",

abstract = "Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.",

author = "Gu, \{Ai Di\} and Mo, \{Hao Yuan\} and Bei, \{Jin Xin\} and Xie, \{Yan Bo\} and Chen, \{Li Zhen\} and Feng, \{Qi Sheng\} and Tiebang Kang and Zeng, \{Yi Xin\}",

year = "2009",

month = apr,

doi = "10.1128/CVI.00207-08",

language = "英语",

volume = "16",

pages = "592--593",

journal = "Clinical and Vaccine Immunology",

issn = "1556-6811",

publisher = "American Society for Microbiology",

number = "4",

}

TY - JOUR

T1 - Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma

AU - Gu, Ai Di

AU - Mo, Hao Yuan

AU - Bei, Jin Xin

AU - Xie, Yan Bo

AU - Chen, Li Zhen

AU - Feng, Qi Sheng

AU - Kang, Tiebang

AU - Zeng, Yi Xin

PY - 2009/4

Y1 - 2009/4

N2 - Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.

AB - Epstein-Barr virus nuclear antigen 1 (EBNA1) is a protein expressed consistently in nasopharyngeal carcinoma (NPC). Although antibody levels against three different EBNA1 peptides were all high in NPC patients, the correlation between any two biomarkers was low. Therefore, the selection of distinct EBNA1 peptides could render different results in serological detection for individuals with NPC.

UR - https://www.scopus.com/pages/publications/64549085963

U2 - 10.1128/CVI.00207-08

DO - 10.1128/CVI.00207-08

M3 - 文章

C2 - 19279168

AN - SCOPUS:64549085963

SN - 1556-6811

VL - 16

SP - 592

EP - 593

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

IS - 4

ER -

Evaluation of antibodies against different epstein-barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma

摘要

访问文件

其它文件与链接

指纹

引用此